Editorial, News & commercial office:
55/A, H M Siddique Mansion (Level-7), Purana Paltan, Motijhel C/A, Dhaka-1000. Phone: +8802226640056,
e-mail: [email protected], [email protected]
Editorial, News & commercial office:
55/A, H M Siddique Mansion (Level-7), Purana Paltan, Motijhel C/A, Dhaka-1000. Phone: +8802226640056,
e-mail: [email protected], [email protected]
Transcom Beverages Limited Managing Director Simeen Rahman failed to appear before a court on the scheduled date in a case alleging excessive levels of artificial sweeteners in 7Up, while a summons issued against her was also not properly served. The court has consequently fixed a new date for the hearing.
Meanwhile, sales of 7Up have continued in the market despite the allegations, with the beverage still being sold at various locations.
The case was filed over allegations that laboratory tests detected artificial sweeteners in 7Up beyond the prescribed limits. Simeen Rahman, managing director of Transcom Beverages Limited, the company responsible for marketing the product in Bangladesh, has been named as the sole accused.
On November 16, the Food Safety Court issued a summons requiring her to appear before it.
Court sources said Simeen Rahman did not appear on Monday, the scheduled date. The court also could not confirm whether the summons had been properly served on her. As a result, a new hearing date has been set.
Concerned parties have alleged that delays in properly serving the summons, reportedly due to negligence in the police process, are holding up the legal proceedings. They said the delay has also complicated efforts to take effective action regarding the sale of the beverage. Questions have also been raised over the lack of visible initiatives by the Directorate of National Consumer Rights Protection, the Bangladesh Standards and Testing Institution (BSTI) and other relevant regulatory agencies.
According to the case documents, laboratory tests of 7Up samples allegedly detected excessive levels of aspartame (methyl ester) and acesulfame potassium. The International Agency for Research on Cancer (IARC), the cancer research agency of the World Health Organization (WHO), has classified aspartame as a substance possibly carcinogenic to humans under Group 2B.
On July 14, 2023, the WHO published assessments concerning the potential health risks of aspartame. The evaluation involved the IARC and the Joint FAO/WHO Expert Committee on Food Additives (JECFA), a joint expert body of the World Health Organization and the Food and Agriculture Organization of the United Nations.
Group 2B includes substances for which limited evidence of carcinogenicity in humans is available. Research has also examined a possible association between aspartame consumption and hepatocellular carcinoma, a type of liver cancer. However, classification under Group 2B does not mean that a substance is conclusively proven to cause cancer.
Acesulfame potassium, meanwhile, is a zero-calorie artificial sweetener used in various food and beverage products. It is approximately 200 times sweeter than regular sugar. The complaint alleges that the amount detected in 7Up also exceeded the permitted limit.
Experts have raised health concerns over excessive consumption of artificial sweeteners. Aspartame is particularly unsuitable for people with phenylketonuria (PKU), a rare condition in which the body cannot properly metabolise phenylalanine.
The lawsuit also highlights alleged discrepancies between the laboratory findings and the standards set by BSTI. According to the complaint, the maximum permitted level of acesulfame potassium is 300 milligrams per specified unit, whereas laboratory tests reportedly found 450 milligrams.
Similarly, the prescribed maximum level of aspartame is 700 milligrams, while the test results allegedly showed 1,000 milligrams.
Sources connected with the case further claimed that significant deviations were detected in five of the six parameters examined during the laboratory's chemical analysis.
Against this backdrop, concerned parties have called for the withdrawal of the allegedly non-compliant batches of 7Up from the market and an immediate investigation into the matter. They fear that failure to take appropriate action could expose ordinary consumers, including children and adolescents, to potential health risks.
Shafiquzzaman, president of the Consumers Association of Bangladesh (CAB), said products proven to be substandard should be promptly withdrawn from the market.
He questioned why such action had not been taken in this case, stressing that the relevant authorities should explain their position. The matter should be treated seriously, as there should be no compromise when public health is at stake. CAB would also look into the issue, he added.
Mahbub Kabir Milon, who works on consumer rights and food safety issues, said failure to comply with the Bangladesh Standards (BDS) constitutes a punishable offence. He said 7Up could not evade responsibility if the allegations were established.
He also noted that even if a product meets the prescribed standards, failure to provide the required information on its label could constitute a punishable offence.
Attempts were made several times to obtain comments from Sharifuddin Shyamol, head of brand at Transcom Beverages Limited, but he did not answer phone calls. Questions were subsequently sent to him via WhatsApp, but no response was received.
Emails seeking comments were also sent to Transcom Beverages Limited and PepsiCo, the parent company of 7Up. No response had been received from either organisation until the report was filed.
https://thedailyexpress.news/news/business/1f1e267c-afd4-61e0-986b-4e11b8e8602a